Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The objective of this present study was to asses the pharmacokinetic properties of acyclovir tablet from new product formulation (PT. Kimia Farma (Persero) Tbk) to its innovator product, Zovirax® tablet (Glaxo Wellcome S.A., Aranda, Spain)
Epistemonikos ID: 57c6ce20f0e8127967cebcc26157ba8cc7f40809
First added on: May 09, 2024